Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

Summary

Gastric cancer is a high incidence in Asia, and one of the leading cause of death in Korea. A cure rate is improving due to early diagnosis. However, the 5-year survival rate of gastric cancer excluding early gastric cancer is about 40 \~ 67%. Therefore, several methods for lowering the recurrence rate have been attempted and concurrent chemoradiotherapy can be considered as a method to lower the recurrence rate of gastric cancer. The purpose of this study is to evaluate the pathologic response rate and safety of patients who underwent surgery after chemoradiotherapy.

Timeline

Start

2016-12-12

Primary completion

2021-12-31

Completion

2022-07-31

Drugs

Indications